The topical treatment of old world cutaneous leishmaniasis with gentian violet along with cryotherapy: a pilot single-blind randomized controlled clinical trial

Abstract INTRODUCTION: The promising non-clinical antileishmanial effects of gentian violet (GV) encouraged us to evaluate the additive effect of GV on cryotherapy. METHODS: For 8 weeks, 59/161 cutaneous leishmaniasis patients/lesions underwent cryotherapy alone (group 1) or cryotherapy accompanied by 1% GV application (group 2). The primary endpoint was clinical response. RESULTS: Ultimately, 54.7% and 45.3% of the significantly cured lesions belonged to groups 1 and 2, respectively, which was not statistically significant. The clinical response was significantly different between the two groups at the end of the fourth week. CONCLUSIONS: Although the clinical response of the two groups was significantly different at the end of the fourth week, application of GV did not increase the efficacy of cryotherapy.

Saved in:
Bibliographic Details
Main Authors: Sepaskhah,Mozhdeh, Behdad,Kasra, Bagheri,Zahra
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Medicina Tropical - SBMT 2019
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822019000100629
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0037-86822019000100629
record_format ojs
spelling oai:scielo:S0037-868220190001006292019-04-09The topical treatment of old world cutaneous leishmaniasis with gentian violet along with cryotherapy: a pilot single-blind randomized controlled clinical trialSepaskhah,MozhdehBehdad,KasraBagheri,Zahra Leishmaniasis Treatment Topical Gentian violet Cryotherapy Abstract INTRODUCTION: The promising non-clinical antileishmanial effects of gentian violet (GV) encouraged us to evaluate the additive effect of GV on cryotherapy. METHODS: For 8 weeks, 59/161 cutaneous leishmaniasis patients/lesions underwent cryotherapy alone (group 1) or cryotherapy accompanied by 1% GV application (group 2). The primary endpoint was clinical response. RESULTS: Ultimately, 54.7% and 45.3% of the significantly cured lesions belonged to groups 1 and 2, respectively, which was not statistically significant. The clinical response was significantly different between the two groups at the end of the fourth week. CONCLUSIONS: Although the clinical response of the two groups was significantly different at the end of the fourth week, application of GV did not increase the efficacy of cryotherapy.info:eu-repo/semantics/openAccessSociedade Brasileira de Medicina Tropical - SBMTRevista da Sociedade Brasileira de Medicina Tropical v.52 20192019-01-01info:eu-repo/semantics/othertext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822019000100629en10.1590/0037-8682-0278-2018
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Sepaskhah,Mozhdeh
Behdad,Kasra
Bagheri,Zahra
spellingShingle Sepaskhah,Mozhdeh
Behdad,Kasra
Bagheri,Zahra
The topical treatment of old world cutaneous leishmaniasis with gentian violet along with cryotherapy: a pilot single-blind randomized controlled clinical trial
author_facet Sepaskhah,Mozhdeh
Behdad,Kasra
Bagheri,Zahra
author_sort Sepaskhah,Mozhdeh
title The topical treatment of old world cutaneous leishmaniasis with gentian violet along with cryotherapy: a pilot single-blind randomized controlled clinical trial
title_short The topical treatment of old world cutaneous leishmaniasis with gentian violet along with cryotherapy: a pilot single-blind randomized controlled clinical trial
title_full The topical treatment of old world cutaneous leishmaniasis with gentian violet along with cryotherapy: a pilot single-blind randomized controlled clinical trial
title_fullStr The topical treatment of old world cutaneous leishmaniasis with gentian violet along with cryotherapy: a pilot single-blind randomized controlled clinical trial
title_full_unstemmed The topical treatment of old world cutaneous leishmaniasis with gentian violet along with cryotherapy: a pilot single-blind randomized controlled clinical trial
title_sort topical treatment of old world cutaneous leishmaniasis with gentian violet along with cryotherapy: a pilot single-blind randomized controlled clinical trial
description Abstract INTRODUCTION: The promising non-clinical antileishmanial effects of gentian violet (GV) encouraged us to evaluate the additive effect of GV on cryotherapy. METHODS: For 8 weeks, 59/161 cutaneous leishmaniasis patients/lesions underwent cryotherapy alone (group 1) or cryotherapy accompanied by 1% GV application (group 2). The primary endpoint was clinical response. RESULTS: Ultimately, 54.7% and 45.3% of the significantly cured lesions belonged to groups 1 and 2, respectively, which was not statistically significant. The clinical response was significantly different between the two groups at the end of the fourth week. CONCLUSIONS: Although the clinical response of the two groups was significantly different at the end of the fourth week, application of GV did not increase the efficacy of cryotherapy.
publisher Sociedade Brasileira de Medicina Tropical - SBMT
publishDate 2019
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822019000100629
work_keys_str_mv AT sepaskhahmozhdeh thetopicaltreatmentofoldworldcutaneousleishmaniasiswithgentianvioletalongwithcryotherapyapilotsingleblindrandomizedcontrolledclinicaltrial
AT behdadkasra thetopicaltreatmentofoldworldcutaneousleishmaniasiswithgentianvioletalongwithcryotherapyapilotsingleblindrandomizedcontrolledclinicaltrial
AT bagherizahra thetopicaltreatmentofoldworldcutaneousleishmaniasiswithgentianvioletalongwithcryotherapyapilotsingleblindrandomizedcontrolledclinicaltrial
AT sepaskhahmozhdeh topicaltreatmentofoldworldcutaneousleishmaniasiswithgentianvioletalongwithcryotherapyapilotsingleblindrandomizedcontrolledclinicaltrial
AT behdadkasra topicaltreatmentofoldworldcutaneousleishmaniasiswithgentianvioletalongwithcryotherapyapilotsingleblindrandomizedcontrolledclinicaltrial
AT bagherizahra topicaltreatmentofoldworldcutaneousleishmaniasiswithgentianvioletalongwithcryotherapyapilotsingleblindrandomizedcontrolledclinicaltrial
_version_ 1756380653232848896